A Universal, Continuous Assay for SAM‐dependent Methyltransferases
Marian J. Menke, Pascal Schneider, Christoffel P. S. Badenhorst, Andreas Kunzendorf, F Heinz, Mark Dörr, Martin A. Hayes, Uwe T. Bornscheuer
Abstract
Abstract Enzyme‐catalyzed late‐stage functionalization (LSF), such as methylation of drug molecules and lead structures, enables direct access to more potent active pharmaceutical ingredients (API). S ‐adenosyl‐ l ‐methionine‐dependent methyltransferases (MTs) can play a key role in the development of new APIs, as they catalyze the chemo‐ and regioselective methylation of O ‐, N ‐, S ‐ and C ‐atoms, being superior to traditional chemical routes. To identify suitable MTs, we developed a continuous fluorescence‐based, high‐throughput assay for SAM‐dependent methyltransferases, which facilitates screening using E. coli cell lysates. This assay involves two enzymatic steps for the conversion of S ‐adenosyl‐ l ‐homocysteine into H 2 S to result in a selective fluorescence readout via reduction of an azidocoumarin sulfide probe. Investigation of two O ‐MTs and an N ‐MT confirmed that this assay is suitable for the determination of methyltransferase activity in E. coli cell lysates.